| Old Articles: <Older 2011-2020 Newer> |
|---|
 |
Chemistry World
January 22, 2013
Andrew Turley |
Flu vaccine without the eggs approved Flublok from US biotech Protein Sciences has become the first flu vaccine made using an insect virus to win marketing approval in the US.   |
Chemistry World
January 18, 2013
Emma Eley |
New method to target malaria Malaria affects millions of people each year; however, no effective vaccines exist. Now, scientists from Spain have discovered a new strategy to target the disease. |
AskMen.com
January 15, 2013
Michael McKenna |
Quitting Booze: Part 2 I want to know exactly how much personal intensity is sapped by (let's say) communing with spirits, and I want this knowledge to inform my future ways and days. I want to have all of the information I need. |
AskMen.com
January 8, 2013
Michael McKenna |
Quitting Drinking: Part 1 Like so many Julian-calendar-observing hangover sufferers, I woke last Tuesday to the joyless alarm of my own self-imposed resolutions. |
AskMen.com
January 7, 2013
Tony Horton |
Sleep More, Stress Less Sleep and stress management are the linchpin for good health and give you the willpower to make better choices. Stress less, sleep more and strive to be Joe Way Above Average. |
Chemistry World
January 3, 2013
Andrew Turley |
TB drug milestone for bedaquiline Bedaquiline (sirturo) has become the first drug to be approved in the US for the treatment of multi-drug resistant tuberculosis |
Chemistry World
December 19, 2012
Amy Middleton-Gear |
Early Alzheimer's diagnosis compound UK and US scientists have developed a labelled tracer compound that binds to plaques closely associated with Alzheimer's disease so that the plaques can be picked up by a medical imaging technique. |
Chemistry World
December 18, 2012
Jennifer Newton |
Technique to measure chemotherapy effectiveness A technique to measure how effective chemotherapy is by studying the physical changes that occur in human cells has been developed by US scientists. |
Chemistry World
December 17, 2012
Jessica Cocker |
Helping the fight against flu Scientists from Australia and the US have developed a synthesis for a drug that gives higher yields and antiviral activity than currently used commercial drugs, such as Relenza (zanamivir) and Tamiflu (oseltamivir), they claim. |
Information Today
December 13, 2012 |
PubReader: A New Way to Read Articles in PubMed Central The National Center for Biotechnology Information developed a new presentation style called PubReader, an easier way to use your web browser to read articles in PubMed Central on your desktop, laptop, or tablet computer. |
| <Older 2011-2020 Newer> Return to current articles. |
